| Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer V Noronha, VM Patil, A Joshi, N Menon, A Chougule, A Mahajan, A Janu, ... Journal of Clinical Oncology 38 (2), 124-136, 2020 | 354 | 2020 |
| Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial V Noronha, A Joshi, VM Patil, J Agarwal, S Ghosh-Laskar, A Budrukkar, ... Journal of Clinical Oncology 36 (11), 1064-1072, 2018 | 309 | 2018 |
| A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer VM Patil, V Noronha, A Joshi, J Agarwal, S Ghosh‐Laskar, A Budrukkar, ... Cancer 125 (18), 3184-3197, 2019 | 103 | 2019 |
| A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable … VM Patil, V Noronha, A Joshi, VK Muddu, S Dhumal, B Bhosale, S Arya, ... Oral oncology 51 (3), 279-286, 2015 | 83 | 2015 |
| Low-dose immunotherapy in head and neck cancer: a randomized study VM Patil, V Noronha, N Menon, R Rai, A Bhattacharjee, A Singh, ... Journal of Clinical Oncology 41 (2), 222-232, 2023 | 77 | 2023 |
| Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group … V Patil, V Noronha, SB Dhumal, A Joshi, N Menon, A Bhattacharjee, ... The Lancet Global Health 8 (9), e1213-e1222, 2020 | 74 | 2020 |
| Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma VM Patil, V Noronha, A Joshi, AB Choughule, A Bhattacharjee, R Kumar, ... ESMO open 2 (1), e000168, 2017 | 64 | 2017 |
| Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early-failure oral cancer VM Patil, V Noronha, A Joshi, S Dhumal, M Mahimkar, A Bhattacharjee, ... Journal of clinical oncology 37 (32), 3032-3041, 2019 | 60 | 2019 |
| Neoadjuvant chemotherapy in locally advanced and borderline resectable nonsquamous sinonasal tumors (esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation) VM Patil, A Joshi, V Noronha, V Sharma, S Zanwar, S Dhumal, S Kane, ... International Journal of Surgical Oncology 2016, 2016 | 46 | 2016 |
| Salvage surgery in head and neck cancer: Does it improve outcomes? VM Patil, V Noronha, S Thiagarajan, A Joshi, A Chandrasekharan, ... European Journal of Surgical Oncology 46 (6), 1052-1058, 2020 | 35 | 2020 |
| Immunological interactions in radiotherapy—opening a new window of opportunity T Bhattacharyya, K Purushothaman, SSV Puthiyottil, A Bhattacharjee, ... Annals of Translational Medicine 4 (3), 2016 | 27 | 2016 |
| Metronomic chemotherapy in platinum-insensitive failures and/or early failures postmultimodality management in oral cancers VM Patil, V Noronha, A Joshi, R Pinninti, S Dhumal, A Bhattacharjee, ... Indian Journal of Medical and Paediatric Oncology 36 (03), 161-165, 2015 | 25 | 2015 |
| Performance based market valuation of cricketers in IPL H Saikia, D Bhattacharjee, A Bhattacharjee Sport, Business and Management: An International Journal 3 (2), 127-146, 2013 | 25 | 2013 |
| SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study S Dhumal, A Patil, A More, S Kamtalwar, A Joshi, A Gokarn, S Mirgh, ... International Journal of Infectious Diseases 118, 95-103, 2022 | 23 | 2022 |
| Distance correlation coefficient: An application with bayesian approach in clinical data analysis A Bhattacharjee Journal of Modern Applied Statistical Methods 13, 354-366, 2014 | 23 | 2014 |
| When COVID-19 will decline in India? Prediction by combination of recovery and case load rate A Bhattacharjee, M Kumar, KK Patel Clinical epidemiology and global health 9, 17-20, 2021 | 22 | 2021 |
| Resveratrol and Copper for treatment of severe COVID-19: an observational study (RESCU 002) I Mittra, R de Souza, R Bhadade, T Madke, PD Shankpal, M Joshi, ... medRxiv, 2020.07. 21.20151423, 2020 | 21 | 2020 |
| Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method M Narasimhan, S Kannan, A Chawade, A Bhattacharjee, R Govekar Journal of translational medicine 17, 1-15, 2019 | 21 | 2019 |
| Next generation metronomic chemotherapy—report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6–8 May 2016, Mumbai P Pantziarka, L Hutchinson, N André, S Benzekry, F Bertolini, ... ecancermedicalscience 10, 2016 | 20 | 2016 |
| Is IPL responsible for cricketers’ performance in Twenty20 World Cup H Saikia, D Bhattacharjee, A Bhattacharjee International Journal of Sports Science and Engineering 6 (2), 96-110, 2012 | 20 | 2012 |
Vanita NoronhaProfessor, Tata Memorial HospitalAdresse e-mail validée de tmc.gov.in
